Cargando…
Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values
We investigated selected pro/antioxidant parameters in a group of women with polycystic ovary syndrome (PCOS) divided according to age, body mass index (BMI), waist-to-hip ratio (WHR), homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (Qui...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328171/ https://www.ncbi.nlm.nih.gov/pubmed/35884870 http://dx.doi.org/10.3390/biomedicines10071564 |
_version_ | 1784757653095841792 |
---|---|
author | Niepsuj, Justyna Franik, Grzegorz Madej, Paweł Piwowar, Agnieszka Bizoń, Anna |
author_facet | Niepsuj, Justyna Franik, Grzegorz Madej, Paweł Piwowar, Agnieszka Bizoń, Anna |
author_sort | Niepsuj, Justyna |
collection | PubMed |
description | We investigated selected pro/antioxidant parameters in a group of women with polycystic ovary syndrome (PCOS) divided according to age, body mass index (BMI), waist-to-hip ratio (WHR), homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (Quicki). We chose oxidized low-density lipoproteins (oxLDL-C) as a marker of oxidative stress and the ferric reducing ability of plasma (FRAP) as a marker of antioxidant status. In women with PCOS, the values of BMI, WHR, age and concentration of glucose significantly affected oxLDL-C concentration and FRAP values. FRAP correlated with oxLDL-C level in the whole group and in women who were insulin sensitive (HOMA-IR < 2.0). There was a negative relationship between the concentration of Anti-Müllerian hormone and both oxLDL-C and FRAP. Furthermore, the value of FRAP was inversely correlated with luteinizing hormone (LH), follicle-stimulating hormone (FSH) and androstenedione, whereas it was positively correlated with the LH/FSH ratio. The concentration of oxLDL and the value of FRAP are significantly associated with selected metabolic and hormonal parameters in the course of PCOS. |
format | Online Article Text |
id | pubmed-9328171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93281712022-07-28 Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values Niepsuj, Justyna Franik, Grzegorz Madej, Paweł Piwowar, Agnieszka Bizoń, Anna Biomedicines Article We investigated selected pro/antioxidant parameters in a group of women with polycystic ovary syndrome (PCOS) divided according to age, body mass index (BMI), waist-to-hip ratio (WHR), homeostatic model assessment for insulin resistance (HOMA-IR) and quantitative insulin sensitivity check index (Quicki). We chose oxidized low-density lipoproteins (oxLDL-C) as a marker of oxidative stress and the ferric reducing ability of plasma (FRAP) as a marker of antioxidant status. In women with PCOS, the values of BMI, WHR, age and concentration of glucose significantly affected oxLDL-C concentration and FRAP values. FRAP correlated with oxLDL-C level in the whole group and in women who were insulin sensitive (HOMA-IR < 2.0). There was a negative relationship between the concentration of Anti-Müllerian hormone and both oxLDL-C and FRAP. Furthermore, the value of FRAP was inversely correlated with luteinizing hormone (LH), follicle-stimulating hormone (FSH) and androstenedione, whereas it was positively correlated with the LH/FSH ratio. The concentration of oxLDL and the value of FRAP are significantly associated with selected metabolic and hormonal parameters in the course of PCOS. MDPI 2022-06-30 /pmc/articles/PMC9328171/ /pubmed/35884870 http://dx.doi.org/10.3390/biomedicines10071564 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Niepsuj, Justyna Franik, Grzegorz Madej, Paweł Piwowar, Agnieszka Bizoń, Anna Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values |
title | Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values |
title_full | Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values |
title_fullStr | Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values |
title_full_unstemmed | Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values |
title_short | Evaluation of Pro/Antioxidant Imbalance in Blood of Women with Polycystic Ovary Syndrome Based on Determination of Oxidized Low-Density Lipoproteins and Ferric Reducing Ability of Plasma Values |
title_sort | evaluation of pro/antioxidant imbalance in blood of women with polycystic ovary syndrome based on determination of oxidized low-density lipoproteins and ferric reducing ability of plasma values |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328171/ https://www.ncbi.nlm.nih.gov/pubmed/35884870 http://dx.doi.org/10.3390/biomedicines10071564 |
work_keys_str_mv | AT niepsujjustyna evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues AT franikgrzegorz evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues AT madejpaweł evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues AT piwowaragnieszka evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues AT bizonanna evaluationofproantioxidantimbalanceinbloodofwomenwithpolycysticovarysyndromebasedondeterminationofoxidizedlowdensitylipoproteinsandferricreducingabilityofplasmavalues |